Page 118 - AIH-2-1

Artificial Intelligence in Health ML approach for client and program effects in OUD retention

9. Weinstein ZM, Kim HW, Cheng DM, et al. Long- doi: 10.1111/ajad.13097
term retention in office based opioid treatment with 20. Weller BE, Harrison J, Adkison-Johnson C. Training a
buprenorphine. J Subst Abuse Treat. 2017;74:65-70.
diverse workforce to address the opioid crisis. Soc Work
doi: 10.1016/j.jsat.2016.12.010 Mental Health. 2021;19(6):568-582.
10. Acevedo A, Garnick D, Ritter G, Horgan C, Lundgren L. Race/ doi: 10.1080/15332985.2021.1975014
ethnicity and quality indicators for outpatient treatment for 21. Guerrero EG, Kong Y, Khachikian T, Wang S, D’Aunno T,
substance use disorders. Am J Addict. 2015;24(6):523-531. Howard D. Workforce Diversity and Disparities in Opioid
doi: 10.1111/ajad.12256 Treatment Wait Time and Retention. Research Square.
Preprint; 2022.
11. Mennis J, Stahler GJ, El Magd SA, Baron DA. How long
does it take to complete outpatient substance use disorder doi: 10.21203/rs.3.rs-1651284/v1
treatment? Disparities among blacks, hispanics, and whites 22. Alaa A, Schaar M. Limits of estimating heterogeneous
in the US. Addict Behav. 2019;93:158-165. treatment effects: Guidelines for practical algorithm design.
doi: 10.1016/j.addbeh.2019.01.041 Proc Mach Learn Res. 2018;80:129-38.
12. Guerrero EG. Managerial capacity and adoption of culturally 23. Angus DC, Chang CC. Heterogeneity of treatment effect:
competent practices in outpatient substance abuse treatment Estimating how the effects of interventions vary across
organizations. J Subst Abuse Treat. 2010;39(4):329-339. individuals. JAMA. 2021;326(22):2312-2313.
doi: 10.1016/j.jsat.2010.07.004 doi: 10.1001/jfama.2021.20552
13. Guerrero EG. Enhancing access and retention in 24. Kong Y, Zhou J, Zheng Z, Amaro H, Guerrero EG. Using
substance abuse treatment: The role of Medicaid payment machine learning to advance disparities research: Subgroup
acceptance and cultural competence. Drug Alcohol Depend. analyses of access to opioid treatment. Health Serv Res.
2013;132(3):555-561. 2021;57(2):411-421.
doi: 10.1016/j.drugalcdep.2013.04.005 doi: 10.1111/1475-6773.13896
14. Guerrero EG, Campos M, Urada D, Yang JC. Do cultural 25. Künzel SR, Sekhon JS, Bickel PJ, Yu B. Metalearners for
and linguistic competence matter in Latinos’ completion estimating heterogeneous treatment effects using machine
of mandated substance abuse treatment? Subst Abuse Treat learning. Proc Natl Acad Sci U S A. 2019;116(10):4156-4165.
Prev Policy. 2012;7:827-836. doi: 10.1073/pnas.1804597116
doi: 10.1186/1747-597x-7-34 26. Hill JL. Bayesian nonparametric modeling for causal
15. Guerrero EG, Khachikian T, Kim T, Kong Y, Vega WA. inference. J Comput Graph Stat. 2011;20(1):217-240.
Spanish language proficiency among providers and Latino 27. Grimmer J, Messing S, Westwood SJ. Estimating
clients’ engagement in substance abuse treatment. Addict heterogeneous treatment effects and the effects of
Behav. 2013;38(12):2893-2897. heterogeneous treatments with ensemble methods. Polit
doi: 10.1016/j.addbeh.2013.08.022 Anal. 25(4):413-434.
16. Guerrero E, Andrews CM. Cultural competence in doi: 10.1017/pan.2017.15
outpatient substance abuse treatment: Measurement and 28. Athey S, Tibshirani J, Wager S. Generalized random forests.
relationship to wait time and retention. Drug Alcohol Ann Stat. 2019;47(2):1148-1178.
Depend. 2011;119(1-2):e13-e22.
doi: 10.1214/18-AOS1709
doi: 10.1016/j.drugalcdep.2011.05.020
29. Wager S, Athey S. Estimation and inference of heterogeneous
17. Howard DL. Are the treatment goals of culturally competent treatment effects using random forests. J Am Stat Assoc.
outpatient substance abuse treatment units congruent with 2018;113(523):1228-1242.
their client profile? J Subst Abuse Treat. 2003;24(2):103-113.
doi: 10.1080/01621459.2017.1319839
doi: 10.1016/s0740-5472(02)00349-5
30. D’Aunno T, Park SE, Pollack HA. Evidence-based
18. Howard DL. Culturally competent treatment of African treatment for opioid use disorders: A national study of
American clients among a national sample of outpatient methadone dose levels, 2011-2017. J Subst Abuse Treat.
substance abuse treatment units. J Subst Abuse Treat. 2019;96:18-22.
2003;24(2):89-102.
doi: 10.1016/j.jsat.2018.10.006
doi: 10.1016/s0740-5472(02)00348-3
31. D’Aunno T, Pollack HA, Frimpong JA, Wuchiett D.
19. Jordan A, Jegede O. Building outreach and diversity in the Evidence-based treatment for opioid disorders: A 23-year
field of addictions. Am J Addict. 2020;29(5):413-417. national study of methadone dose levels. J Subst Abuse Treat.

Volume 2 Issue 1 (2025) 112 doi: 10.36922/aih.3750